Cemiplimab for locally advanced and metastatic basal cell carcinoma

Damsin, T; Lebas, E; Marchal, N; Rorive, A; Nikkels, AF

Nikkels, AF (通讯作者),Univ Hosp Ctr, Skin Canc Ctr, Dept Dermatol, CHU Sart Tilman, Liege, Belgium.

EXPERT REVIEW OF ANTICANCER THERAPY, 2022; 22 (3): 243

Abstract

Introduction Locally advanced basal cell carcinoma (laBCC) represents approximatively 1% of all BCCs. Metastatic BCC (mBCC) is even more rare. Most ca......

Full Text Link